---
title: "McKesson Completes Sale of Norwegian Businesses to NorgesGruppen"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274313217.md"
datetime: "2026-01-30T13:01:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274313217.md)
  - [en](https://longbridge.com/en/news/274313217.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274313217.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274313217.md) | [繁體中文](https://longbridge.com/zh-HK/news/274313217.md)


# McKesson Completes Sale of Norwegian Businesses to NorgesGruppen

McKesson Corporation has completed the sale of its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group. This move marks the company’s final step in fully exiting its European operations and allows McKesson to focus on expanding its growth platforms in Oncology, Multispecialty, and Biopharma Services. Further details about the divestiture will be provided during the company’s upcoming Fiscal Third Quarter Earnings call and on its Investor Relations website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260129535115) on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-CN/quote/IHI.US.md)
- [VanEck Pharmaceutical ETF (PPH.US)](https://longbridge.com/zh-CN/quote/PPH.US.md)
- [Maxwealth CSI All Share Medical Apparatus and Instruments ETF (159883.CN)](https://longbridge.com/zh-CN/quote/159883.CN.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-CN/quote/LABU.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-CN/quote/IHE.US.md)
- [GF CSI All Share Health Care ETF (159938.CN)](https://longbridge.com/zh-CN/quote/159938.CN.md)
- [SPDR Pharmac (XPH.US)](https://longbridge.com/zh-CN/quote/XPH.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-CN/quote/PBE.US.md)
- [Proshares UltraShort Nasdaq Biotech (BIS.US)](https://longbridge.com/zh-CN/quote/BIS.US.md)
- [China Merchants CSI All Share Medical Apparatus and Instruments ETF (159898.CN)](https://longbridge.com/zh-CN/quote/159898.CN.md)
- [Direxion S&P Biotech Bear 3X (LABD.US)](https://longbridge.com/zh-CN/quote/LABD.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-CN/quote/BBH.US.md)
- [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-CN/quote/510660.CN.md)
- [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-CN/quote/XHE.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-CN/quote/FBT.US.md)
- [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-CN/quote/512010.CN.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md)
- [Invesco Pharmaceuticals ETF (PJP.US)](https://longbridge.com/zh-CN/quote/PJP.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md)
- [ChinaAMC CSI All Share Health Care Devices ETF (562600.CN)](https://longbridge.com/zh-CN/quote/562600.CN.md)
- [China Universal 800 Health Care ETF (159929.CN)](https://longbridge.com/zh-CN/quote/159929.CN.md)

## 相关资讯与研究

- [MedMira Expands McKesson Partnership as Quarterly Revenue Falls and Loss Widens](https://longbridge.com/zh-CN/news/281454296.md)
- [Zymewire Releases 2025 Annual Biopharma Recap, Expanding Proprietary Intelligence with Exclusive Industry Content](https://longbridge.com/zh-CN/news/281399847.md)
- [Canada's Perimeter Medical Imaging prelim Q4 revenue jumps 143%](https://longbridge.com/zh-CN/news/281240360.md)
- [Stocks in Play: Ventripoint Diagnostics Ltd](https://longbridge.com/zh-CN/news/281544776.md)
- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/zh-CN/news/281274047.md)